Ventricular septal rupture secondary to myocardial infarction. Clinical approach and surgical results.

Twenty-four patients underwent operation for ventricular septal rupture secondary to acute myocardial infarction. There were 14 hospital survivors (58%) and two late deaths (8%). There were eight hospital deaths (62%) of 13 patients referred in cardiogenic shock, but only two deaths (18%) of 11 patients not in shock at time of referral.

Long-term results of operations for mitral insufficiency secondary to coronary artery disease.

There are few published reports regarding the long-term results of the operative treatment of significant mitral insufficiency secondary to coronary artery disease. The few available reports deal with mitral replacement and myocardial revascularization. However, we prefer mitral repair to mitral replacement with myocardial revascularization.

Aortic valve replacement in patients with poor ventricular function-early and late results with long-term follow-up.

A series of 62 consecutive patients with an ejection fraction of 0.4 or less (mean 0.28 with a range from 0.

Surgical treatment of mitral insufficiency secondary to coronary artery disease.

From 1970 to 1978, 61 patients were operated upon for mitral insufficiency secondary to coronary artery disease. These patients were between 44 and 71 years of age and all were in Class III or IV of the New York Heart Association Classification. The left ventricular end-diastolic pressure was 15 mm Hg or more in 32 of the 39 patients in whom it was measured.

Mitral valve repair for significant mitral insufficiency.

There has been skepticism since the early days of open heart surgery that good long-term or even short-term results were possible with repair of pure mitral insufficiency. The authors report 145 patients in whom a markedly insufficient mitral valve was repaired 6 months to 17 years previously and another 55 patients in whom repair of the insufficient mitral valve was performed along with myocardial revascularization from 6 months to 7 years previously. Comparative data with other published work reveals superior results with repair than with replacement with Starr-Edwards and Hancock glutaraldehyde-treated porcine valves and with far less emboli.